Overview

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To asses the modulating properties of the cleaved pentapeptide product of GLP-1 amide.
Phase:
Phase 1
Details
Lead Sponsor:
Elahi, Dariush, PhD
Collaborators:
ICON plc
Massachusetts General Hospital
National Institute on Aging (NIA)
Treatments:
Glucagon
Glucagon-Like Peptide 1